The EIU report, “Time to Act Now for Prediabetes”, was commissioned by Merck KGaA to analyze how early interventions in prediabetes can lead to cost-savings in emerging markets (China, Brazil, Mexico, Russia, Indonesia, Saudi Arabia).
The EIU report, “Time to Act Now for Prediabetes”, was commissioned by Merck KGaA to analyze how early interventions in prediabetes can lead to cost-savings in emerging markets (China, Brazil, Mexico, Russia, Indonesia, Saudi Arabia).